Related Experiment Video
Updated: Sep 25, 2025

08:28
Experimental Metastasis Assay
Published on: August 24, 2010
20.4K
The Genetic Evolution of Metastasis.
Aljosja Rogiers1,2, Irene Lobon1, Lavinia Spain1,3,4,5
1Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.
Cancer Research
|April 27, 2022
Summary
Cancer evolves through distinct clones within a tumor, driving metastasis. Understanding tumor genetics can guide anti-metastasis treatments and clinical decisions.
Area of Science:
- Oncology
- Evolutionary Biology
- Genomics
Background:
- Cancer is an evolutionary process.
- Intratumor heterogeneity fuels adaptive clone selection, leading to metastasis.
- Genomic differences between primary tumors and metastases are key.
Purpose of the Study:
- To review how genomic insights into metastasis can inform clinical decisions.
- To explore rational antimetastasis treatment strategies based on molecular studies.
Main Methods:
- Comparative molecular studies of primary tumors and metastases.
- Analysis of genomic features associated with metastatic development.
Main Results:
- Identified distinct genomic features linked to metastasis.
- Highlighted the role of intratumor heterogeneity in adaptive clone selection.
Conclusions:
- Genomic insights can guide clinical decision-making.
- Understanding tumor evolution can uncover novel antimetastasis therapies.
More Related Videos
Related Concept Videos
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancers Originate from Somatic Mutations in a Single Cell
13.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.2K
Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Gene Evolution - Fast or Slow?
7.5K
The genomes of eukaryotes are punctuated by long stretches of sequence which do not code for proteins or RNAs. Although some of these regions do contain crucial regulatory sequences, the vast majority of this DNA serves no known function. Typically, these regions of the genome are the ones in which the fastest change, in evolutionary terms, is observed, because there is typically little to no selection pressure acting on these regions to preserve their sequences.
In contrast, regions which code...
In contrast, regions which code...
7.5K

